home / stock / lctx / lctx short
Short Information | BioTime Inc. (NYSE:LCTX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 86,348 |
Total Actual Volume | 15,162,662 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 4,317 |
Average Short Percentage | 0.66% |
Is there a LCTX Short Squeeze or Breakout about to happen?
See the LCTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-26-2024 | $1.07 | $1.02 | $1.08 | $1 | 614,562 | 1,373 | 0.22% |
07-25-2024 | $1.04 | $1.04 | $1.07 | $1.03 | 530,160 | 1,191 | 0.22% |
07-24-2024 | $1.07 | $1.02 | $1.08 | $1 | 796,712 | 5,454 | 0.68% |
07-23-2024 | $1.01 | $1.12 | $1.15 | $1.01 | 744,034 | 2,080 | 0.28% |
07-22-2024 | $1 | $1.02 | $1.04 | $0.9943 | 432,693 | 106 | 0.02% |
07-19-2024 | $1.02 | $1 | $1.06 | $0.992 | 445,287 | 2,663 | 0.6% |
07-18-2024 | $1.04 | $1.01 | $1.07 | $0.9903 | 434,464 | 7,332 | 1.69% |
07-17-2024 | $1.07 | $1.06 | $1.07 | $1.01 | 493,682 | 4,431 | 0.9% |
07-16-2024 | $1.04 | $1.07 | $1.08 | $1.04 | 705,140 | 4,258 | 0.6% |
07-15-2024 | $0.98 | $1.02 | $1.03 | $0.9601 | 617,977 | 562 | 0.09% |
07-12-2024 | $1.03 | $1.01 | $1.03 | $1 | 475,171 | 3,434 | 0.72% |
07-11-2024 | $0.9474 | $1.02 | $1.03 | $0.9293 | 579,177 | 2,372 | 0.41% |
07-10-2024 | $0.9098 | $0.956 | $0.956 | $0.9098 | 464,128 | 1,687 | 0.36% |
07-09-2024 | $0.8919 | $0.8952 | $0.9199 | $0.8879 | 472,720 | 5,389 | 1.14% |
07-08-2024 | $0.9072 | $0.89 | $0.933499 | $0.88 | 769,365 | 15,383 | 2% |
07-05-2024 | $0.9167 | $0.893 | $0.9303 | $0.8372 | 959,858 | 3,543 | 0.37% |
07-03-2024 | $0.94 | $0.9185 | $0.9433 | $0.9103 | 769,663 | 16,736 | 2.17% |
07-02-2024 | $0.95 | $0.9321 | $0.9599 | $0.9235 | 527,336 | 1,832 | 0.35% |
07-01-2024 | $0.98 | $0.9541 | $0.9801 | $0.95 | 1,027,541 | 3,862 | 0.38% |
06-28-2024 | $1.02 | $0.9973 | $1.02 | $0.94 | 3,302,992 | 2,660 | 0.08% |
News, Short Squeeze, Breakout and More Instantly...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company has been added as a member of the broad-market Russell 3000 ® Index, effective after...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company’s CEO, Brian M. Culley, will present at the 2024 BIO International Convention , on Tue...
Persons with Lived Experience Session Expanded to Include Michaela & Kyle Devins Clinical Session Expanded to Include Neuralink Preclinical Session Expanded to Include Axonis, Novoron, Sania & Rewire Medical Lineage Cell Therapeutics, Inc. (NYSE America...